|
NSF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.107700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.829700E-02 |
| Normal-vs-Stage2 |
8.494000E-01 |
| Normal-vs-Stage3 |
6.012600E-04 |
| Normal-vs-Stage4 |
1.103900E-03 |
| Stage1-vs-Stage2 |
7.542000E-02 |
| Stage1-vs-Stage3 |
2.360200E-02 |
| Stage1-vs-Stage4 |
5.809700E-02 |
| Stage2-vs-Stage3 |
1.219590E-03 |
| Stage2-vs-Stage4 |
3.141700E-03 |
| Stage3-vs-Stage4 |
7.229000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.064100E-03 |
| Normal-vs-AfricanAmerican |
9.489200E-01 |
| Normal-vs-Asian |
4.823900E-02 |
| Caucasian-vs-AfricanAmerican |
5.830200E-02 |
| Caucasian-vs-Asian |
8.453200E-01 |
| AfricanAmerican-vs-Asian |
1.126180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.076200E-03 |
| Normal-vs-Female |
6.142300E-02 |
| Male-vs-Female |
1.826830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.078420E-01 |
| Normal-vs-Age(41-60Yrs) |
1.064350E-02 |
| Normal-vs-Age(61-80Yrs) |
7.034400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.624970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.681960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.577800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.083600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.510000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.229800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.058400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.365700E-02 |
| Classical-VS-Follicular |
1.588040E-01 |
| Classical-VS-Other |
8.603900E-02 |
| Classical-VS-Normal |
3.579500E-02 |
| Tall-VS-Follicular |
6.435000E-03 |
| Tall-VS-Other |
3.164800E-01 |
| Tall-VS-Normal |
9.236000E-04 |
| Follicular-VS-Other |
6.609600E-02 |
| Follicular-VS-Normal |
5.243400E-01 |
| Other-VS-Normal |
4.663300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.863800E-02 |
| Normal-vs-N1 |
8.10260000000396E-05 |
| N0-vs-N1 |
4.941400E-03 |
|
|
